We use cookies for a better user experience. Read our Privacy Policy

I Agree

PCR & Real-time PCR Molecular Diagnostics Market Trends, 2020-2030

PCR & Real-time PCR Molecular Diagnostics Market (Technology: Traditional PCR, Real-time PCR, and Digital PCR; Product: Instruments, Reagents, and Consumables; Application: Infectious Diseases Testing, Oncology Testing, Genetic Testing, and Others; and End User: Hospitals, Diagnostic Laboratories, Academic & Academic & Research Centers, and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Advantages over Alternative Virus Isolation Techniques to Drive Demand

Over the past few decades, polymerase chain reaction (PCR) molecular diagnostics has gradually established itself as one of the most critical laboratory tools. Advancements in PCR & real-time PCR molecular diagnostics are largely driven by minor changes to enzymes and large-scale changes in a particular result. At present, considerable research and development activities are being carried out to improve the reliability and accuracy of PCR & real-time PCR molecular diagnostics– a factor that is expected to bolster the market growth during the forecast period.

The outbreak of the novel COVID-19 pandemic is expected to play an imperative role in accelerating the growth of the global PCR & real-time PCR molecular diagnostics market, as PCR & real-time diagnostics is highly critical to detect virus in individuals who exhibit no symptoms or signs of disease. In addition, the adoption of PCR & real-time PCR molecular diagnostics is on the rise for the identification and detection of Pseudomonas aeruginosa. This is likely to boost the overall prospects of the global PCR & real-time PCR molecular diagnostics market during the assessment period.

Request a sample to get extensive insights into the PCR & Real-time PCR Molecular Diagnostics Market

The increasing collaborations between private scientific laboratories and research institutes is projected to build a solid foundation for the PCR & real-time PCR molecular diagnostics market.

At the back of these factors, along with consistent advancements in technology and virus detection techniques, the global PCR & real-time PCR molecular diagnostics market is expected to surpass US$ 6.5 Bn mark by the end of 2030.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Strides Taken by Quantitative PCR & Real-time PCR Molecular Diagnostics to Aid Market Growth

At present, the various techniques deployed across the molecular biology and medical diagnostics space are highly time-consuming and labor-intensive due to which, researchers and medical experts continue to focus on the discovery of time-efficient, reliable, and effective medical diagnostics. The PCR & real-time PCR molecular diagnostics has garnered considerable popularity over the past couple of decades, as it enables multiplication of a target DNA molecule due to which, the diagnosis of a range of diseases with a higher accuracy was made possible. This factor is anticipated to drive the PCR & real-time PCR molecular diagnostics market during the assessment period.

Researchers and stakeholders involved in the current PCR & real-time PCR molecular diagnostics market are of the opinion that quantitative PCR & real-time PCR molecular diagnostics is a highly robust and reliable medical diagnostics technique. Moreover, PCR & real-time PCR molecular diagnostics have a lower risk of cross-contamination, as it is predominantly carried out in automated thermal cyclers. Moreover, investments for PCR & real-time PCR molecular diagnostics have witnessed consistent growth over the past decade. Moreover, as per current observations, the trend is set to continue in the upcoming decade, due to the tremendous scope of PCR & real-time PCR molecular diagnostics in the near future.

Stuck in a neck-to-neck competition with other brands? Request a custom report on PCR & Real-time PCR Molecular Diagnostics Market

The outbreak of the novel COVID-19 pandemic is expected to boost to the overall growth of the global PCR & real-time PCR molecular diagnostics market. Several established international organizations, including IAEA and Food and Agriculture Organization (FAO) are increasingly offering their support and expertise to various nations to facilitate the adoption of real-time reverse transcription- PCR & real-time PCR molecular diagnostics– one of the most reliable and accurate laboratory techniques used to track, detect, and assess the novel COVID-19 coronavirus strain.

The demand for PCR & real-time PCR molecular diagnostics has witnessed noteworthy growth in 2020, as governments of various nations around the world are increasingly offering monetary and policy-driven support to players involved in the PCR & real-time PCR molecular diagnostics market. In comparison with the alternative virus isolation techniques, PCR & real-time PCR molecular diagnostics has a lower risk of cross-contamination and is notably faster. This is expected to drive the demand for PCR & real-time PCR molecular diagnostics during COVID-19.

Analysts’ Viewpoint

The global PCR & real-time PCR molecular diagnostics market is expected to expand at a moderate CAGR of ~4% during the forecast period. The market growth is primarily driven by factors such as advancements in technology, progress made by quantitative PCR & real-time PCR molecular diagnostics techniques, benefits over other virus isolation and detection techniques, and growing emphasis on improving the reliability of end-results of PCR molecular diagnostics. The demand for PCR & real-time PCR molecular diagnostics has witnessed tremendous growth in 2020, due to the onset of the COVID-19 pandemic. Furthermore, as per current trends, the adoption is likely to gain momentum, as governments around the world continue to take drastic measures to curb the transmission of the COVID-19 virus.  

PCR & Real-time PCR Molecular Market: Overview

  • According to Transparency Market Research’s latest research report on the global PCR & real-time PCR molecular market for the historical year (2018), base year (2019), and the forecast period (2020–2030), technological advancements and increase in burden of cancer & infectious diseases across the globe are projected to drive the global PCR & real-time PCR molecular market in the near future
  • According to the report, the global PCR & real-time PCR molecular market was valued over US$ 4.1 Bn in 2019. It is anticipated to expand at a CAGR of ~4% from 2020 to 2030.

Rise in Burden of Cancer & Infectious Diseases to Drive Global Market

  • Rise in prevalence of cancer and infectious diseases is projected to drive the market during the forecast period. Hepatitis and HIV are major infectious diseases. According to the World Health Organization (WHO), as of October 2017, nearly 71 million people across the world were estimated to be suffering from hepatitis C infection. The organization also stated that 36.7 million people were affected with HIV, globally.
  • According to the WHO, lung, breast, colorectal, prostate, skin, and stomach cancer are common types of cancers that are prevalent across the globe. According to the American Cancer Society, the most common cancers in the U.S. are breast cancer, lung cancer, prostate cancer, colorectal cancer, and melanoma. According to the Urology Care Foundation, about one in every seven men is diagnosed with prostate cancer in the U.S., and approximately, one in 35 men succumbs to the disease. In 2020, 191,000 men are likely to be diagnosed with prostate cancer.

Increase in Demand for Molecular Diagnostic Tools to Propel Global Market

  • Expansion of the market is projected to be driven by technological advancement, regulatory approvals, and increase in adoption of molecular diagnostic tools in oncology and infectious diseases. Early detection plays a significant role in management of cancer. Molecular diagnostics offers a wide range of tools for accurate and reliable diagnosis of diseases. Additionally, PCR-based systems help enhance workflow to reduce the overall cost and eliminate the need for multiple systems.

PCR & Real-time PCR Molecular Market: Competition Landscape

  • This report profiles major players operating in the global PCR & real-time PCR molecular market based on attributes such as company overview, financial overview, product portfolio, major brands, business strategies, and recent developments
  • The global PCR & real-time PCR molecular market is highly competitive with the presence of prominent players in the international market. Top players hold prominent share of the global PCR & real-time PCR molecular market.
  • Prominent players operating in the global PCR & real-time PCR molecular market include
    • Abbott Laboratories
    • Bio-Rad Laboratories, Inc.
    • bioMérieux SA
    • Danaher Corporation
    • Thermo Fisher Scientific, Inc.
    • Becton, Dickinson and Company
    • F. Hoffmann-La Roche Ltd 
    • QIAGEN N.V.
    • Hologic, Inc.
    • GRIFOLS
    • S.A.
    • Genomic Health
    • Seegene, Inc.
  • The report on the global PCR & real-time PCR molecular market discusses individual strategies, followed by company profiles of manufacturers of PCR & real-time PCR molecular systems. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global PCR & real-time PCR molecular market.

PCR and Real-time PCR Molecular Diagnostics Market – Segmentation

 

Technology

  • Traditional PCR
  • Real-time PCR
  • Digital PCR

 

Product

  • Instruments
  • Reagents
  • Consumables

Application

  • Infectious Diseases Testing
    • HCV & HBV
    • Sexually Transmitted Infections
    • Hospital Acquired Infection
    • Respiratory Infections
    • Others
    • Oncology Testing
  • Genetic Testing
  • Others

End User

  • Hospitals
  • Diagnostic Laboratories
  • Academic & Academic & Research Centers
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
PCR & Real-time PCR Molecular Diagnostics Market Trends, 2020-2030

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of PCR & Real-time PCR molecular diagnostics market?

The global PCR & Real-time PCR molecular diagnostics market was worth US$ 4.1 Bn and is projected to reach a value of US$ 6.5 Bn by the end of 2030

What is the anticipated CAGR of the PCR & Real-time PCR molecular diagnostics market in the forecast period?

PCR & Real-time PCR molecular diagnostics market is anticipated to grow at a CAGR of 4% during the forecast period

Which region is expected to project the highest market share in the global PCR & Real-time PCR molecular diagnostics market?

North America accounted for a major share of the global PCR & Real-time PCR molecular diagnostics market

What are the key driving factors for the growth of the PCR & Real-time PCR molecular diagnostics market?

PCR & Real-time PCR molecular diagnostics market is driven bt rise in prevalence of cancer and infectious diseases is projected to drive the market during the forecast period

Who are the key players in the global PCR & Real-time PCR molecular diagnostics market?

Key players in the global PCR & Real-time PCR molecular diagnostics market include Abbott Laboratories, Bio-Rad Laboratories, Inc., bioMérieux SA, Danaher Corporation, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd , QIAGEN N.V., Hologic, Inc., GRIFOLS, S.A., Genomic Health, and Seegene, Inc

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global PCR & Real-time PCR Molecular Diagnostics Market

4. Market Overview

    4.1. Introduction

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast, 2018–2030

5. Market Outlook

    5.1. Technology Advancement

    5.2. Key Industry Events (Mergers, Acquisitions, Collaborations, Partnerships, etc.)

    5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short /Mid / Long-term Impact) Pricing Analysis

6. Global PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology

    6.1. Introduction & Definition

    6.2. Global PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030

        6.2.1. Traditional PCR

        6.2.2. Real-time PCR

        6.2.3. Digital PCR

    6.3. Global PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Technology

7. Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product

    7.1. Introduction & Definition

    7.2. Global PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030

        7.2.1. Instruments

        7.2.2. Reagents

        7.2.3. Consumables

    7.3. Global PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Product

8. Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn)  Forecast, by Application

    8.1. Introduction & Definition

    8.2. Global PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030

        8.2.1. Infectious Diseases Testing

            8.2.1.1. HCV & HBV

            8.2.1.2. Sexually Transmitted Infections

            8.2.1.3. Hospital Acquired Infection

            8.2.1.4. Respiratory Infections

            8.2.1.5. Others

        8.2.2. Oncology Testing

        8.2.3. Genetic Testing

        8.2.4. Others

    8.3. Global PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Application

9. Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user

    9.1. Introduction & Definition

    9.2. Global PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2018–2030

        9.2.1. Hospitals

        9.2.2. Diagnostic Laboratories

        9.2.3. Academic & Research Centers

        9.2.4. Others

    9.3. Global PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by End-user

10. Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Region

    10.1. Introduction

    10.2. Global PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Region, 2018–2030

        10.2.1. North America

        10.2.2. Europe

        10.2.3. Asia Pacific

        10.2.4. Latin America

        10.2.5. Middle East & Africa

    10.3. Global PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Region

11. North America PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast

    11.1. Introduction

    11.2. North America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030

        11.2.1. Traditional PCR

        11.2.2. Real-time PCR

        11.2.3. Digital PCR

    11.3. North America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Product, 2018–2030

        11.3.1. Instruments

        11.3.2. Reagents

        11.3.3. Consumables

    11.4. North America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Application, 2018–2030

        11.4.1. Infectious Diseases Testing

            11.4.1.1. HCV & HBV

            11.4.1.2. Sexually Transmitted Infections

            11.4.1.3. Hospital Acquired Infection

            11.4.1.4. Respiratory Infections

            11.4.1.5. Others

        11.4.2. Oncology Testing

        11.4.3. Genetic Testing

        11.4.4. Others

    11.5. North America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2018–2030

        11.5.1. Hospitals

        11.5.2. Diagnostic Laboratories

        11.5.3. Academic & Research Centers

    11.6. North America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Country, 2018–2030

        11.6.1. U.S.

        11.6.2. Canada

    11.7. North America PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis

        11.7.1. By Technology

        11.7.2. By Product

        11.7.3. By Application

        11.7.4. By End-user

        11.7.5. By Country

12. Europe PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast

    12.1. Introduction

    12.2. Europe PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030

        12.2.1. Traditional PCR

        12.2.2. Real-time PCR

        12.2.3. Digital PCR

    12.3. Europe PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Product, 2018–2030

        12.3.1. Instruments

        12.3.2. Reagents

        12.3.3. Consumables

    12.4. Europe PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Application, 2018–2030

        12.4.1. Infectious Diseases Testing

            12.4.1.1. HCV & HBV

            12.4.1.2. Sexually Transmitted Infections

            12.4.1.3. Hospital Acquired Infection

            12.4.1.4. Respiratory Infections

            12.4.1.5. Others

        12.4.2. Oncology Testing

        12.4.3. Genetic Testing

        12.4.4. Others

    12.5. Europe PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2018–2030

        12.5.1. Hospitals

        12.5.2. Diagnostic Laboratories

        12.5.3. Academic & Research Centers

    12.6. Europe PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Country/Sub-region, 2018–2030

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Spain

        12.6.5. Italy

        12.6.6. Rest of Europe

    12.7. Europe PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis

        12.7.1. By Technology

        12.7.2. By Product

        12.7.3. By Application

        12.7.4. By End-user

        12.7.5. By Country/Sub-region

13. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast

    13.1. Introduction

    13.2. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030

        13.2.1. Traditional PCR

        13.2.2. Real-time PCR

        13.2.3. Digital PCR

    13.3. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Product, 2018–2030

        13.3.1. Instruments

        13.3.2. Reagents

        13.3.3. Consumables

    13.4. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Application, 2018–2030

        13.4.1. Infectious Diseases Testing

            13.4.1.1. HCV & HBV

            13.4.1.2. Sexually Transmitted Infections

            13.4.1.3. Hospital Acquired Infection

            13.4.1.4. Respiratory Infections

            13.4.1.5. Others

        13.4.2. Oncology Testing

        13.4.3. Genetic Testing

        13.4.4. Others

    13.5. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2018–2030

        13.5.1. Hospitals

        13.5.2. Diagnostic Laboratories

        13.5.3. Academic & Research Centers

    13.6. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Country/Sub-region, 2018–2030

        13.6.1. Japan

        13.6.2. China

        13.6.3. India

        13.6.4. Australia & New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis

        13.7.1. By Technology

        13.7.2. By Product

        13.7.3. By Application

        13.7.4. By End-user

        13.7.5. By Country/Sub-region

14. Latin America PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast

    14.1. Introduction

    14.2. Latin America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030

        14.2.1. Traditional PCR

        14.2.2. Real-time PCR

        14.2.3. Digital PCR

    14.3. Latin America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Product, 2018–2030

        14.3.1. Instruments

        14.3.2. Reagents

        14.3.3. Consumables

    14.4. Latin America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Application, 2018–2030

        14.4.1. Infectious Diseases Testing

            14.4.1.1. HCV & HBV

            14.4.1.2. Sexually Transmitted Infections

            14.4.1.3. Hospital Acquired Infection

            14.4.1.4. Respiratory Infections

            14.4.1.5. Others

        14.4.2. Oncology Testing

        14.4.3. Genetic Testing

        14.4.4. Others

    14.5. Latin America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2018–2030

        14.5.1. Hospitals

        14.5.2. Diagnostic Laboratories

        14.5.3. Academic & Research Centers

    14.6. Latin America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Country/Sub-region, 2018–2030

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Latin America PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis

        14.7.1. By Technology

        14.7.2. By Product

        14.7.3. By Application

        14.7.4. By End-user

        14.7.5. By Country/Sub-region

15. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast

    15.1. Introduction

    15.2. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030

        15.2.1. Traditional PCR

        15.2.2. Real-time PCR

        15.2.3. Digital PCR

    15.3. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Product, 2018–2030

        15.3.1. Instruments

        15.3.2. Reagents

        15.3.3. Consumables

    15.4. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Application, 2018–2030

        15.4.1. Infectious Diseases Testing

            15.4.1.1. HCV & HBV

            15.4.1.2. Sexually Transmitted Infections

            15.4.1.3. Hospital Acquired Infection

            15.4.1.4. Respiratory Infections

            15.4.1.5. Others

        15.4.2. Oncology Testing

        15.4.3. Genetic Testing

        15.4.4. Others

    15.5. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2018–2030

        15.5.1. Hospitals

        15.5.2. Diagnostic Laboratories

        15.5.3. Academic & Research Centers

    15.6. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Country/Sub-region, 2018–2030

        15.6.1. GCC Countries

        15.6.2. South Africa

        15.6.3. Rest of Middle East & Africa

    15.7. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis

        15.7.1. By Technology

        15.7.2. By Product

        15.7.3. By Application

        15.7.4. By End-user

        15.7.5. By Country/Sub-region

16. Competition Landscape

    16.1. Market Player - Competition Matrix (by tier and size of companies)

    16.2. Global PCR & Real-time PCR Molecular Diagnostics Market Position Analysis, by Company, 2019

    16.3.  Company Profiles

        16.3.1. Abbott Laboratories

            16.3.1.1. Company Description

            16.3.1.2. Business Overview

            16.3.1.3. Financial Overview

            16.3.1.4. Strategic Overview

            16.3.1.5. SWOT Analysis

        16.3.2. Elekta AB Bio-Rad Laboratories, Inc.

            16.3.2.1. Company Description

            16.3.2.2. Business Overview

            16.3.2.3. Financial Overview

            16.3.2.4. Strategic Overview

            16.3.2.5. SWOT Analysis

        16.3.3. bioMérieux SA

            16.3.3.1. Company Description

            16.3.3.2. Business Overview

            16.3.3.3. Financial Overview

            16.3.3.4. Strategic Overview

            16.3.3.5. SWOT Analysis

        16.3.4. Danaher Corporation

            16.3.4.1. Company Description

            16.3.4.2. Business Overview

            16.3.4.3. Strategic Overview

            16.3.4.4. Financial Overview

            16.3.4.5. SWOT Analysis

        16.3.5. Thermo Fisher Scientific, Inc.

            16.3.5.1. Company Description

            16.3.5.2. Business Overview

            16.3.5.3. Strategic Overview

            16.3.5.4. Financial Overview

            16.3.5.5. SWOT Analysis

        16.3.6. Becton, Dickinson and Company

            16.3.6.1. Company Description

            16.3.6.2. Business Overview

            16.3.6.3. Strategic Overview

            16.3.6.4. Financial Overview

            16.3.6.5. SWOT Analysis

        16.3.7. F. Hoffmann-La Roche Ltd

            16.3.7.1. Company Description

            16.3.7.2. Business Overview

            16.3.7.3. Strategic Overview

            16.3.7.4. Financial Overview

            16.3.7.5. SWOT Analysis

        16.3.8. QIAGEN N.V.

            16.3.8.1. Company Description

            16.3.8.2. Business Overview

            16.3.8.3. Strategic Overview

            16.3.8.4. Financial Overview

            16.3.8.5. SWOT Analysis

        16.3.9. Hologic, Inc.

            16.3.9.1. Company Description

            16.3.9.2. Business Overview

            16.3.9.3. Strategic Overview

            16.3.9.4. Financial Overview

            16.3.9.5. SWOT Analysis

        16.3.10. GRIFOLS, S.A.

            16.3.10.1. Company Description

            16.3.10.2. Business Overview

            16.3.10.3. Strategic Overview

            16.3.10.4. Financial Overview

            16.3.10.5. SWOT Analysis

        16.3.11. Genomic Health

            16.3.11.1. Company Description

            16.3.11.2. Business Overview

            16.3.11.3. Strategic Overview

            16.3.11.4. Financial Overview

            16.3.11.5. SWOT Analysis

        16.3.12. Seegene, Inc.

            16.3.12.1. Company Description

            16.3.12.2. Business Overview

            16.3.12.3. Strategic Overview

            16.3.12.4. Financial Overview

            16.3.12.5. SWOT Analysis

List of Tables

Table 01    Global In-vitro Diganostics (IVD) Market for Infectious Disease, Oncology, Genetics Market Value Analysis and Forecast, 2018–2030

Table 02    Global PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Technology, 2018–2030

Table 03    Global PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Product, 2018–2030

Table 04    Global PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Application, 2018–2030

Table 05    Global PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Infectious Diseases, 2018–2030

Table 06    Global PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 07    Global PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Region, 2018–2030

Table 08    North America PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Country, 2018–2030

Table 09    North America PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Technology, 2018–2030

Table 10    North America PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Product, 2018–2030

Table 11    North America PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Application, 2018–2030

Table 12    North America PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Infectious Diseases, 2018–2030

Table 13    North America PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 14    Europe PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 15    Europe PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Technology, 2018–2030

Table 16    Europe PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Product, 2018–2030

Table 17    Europe PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Application, 2018–2030

Table 18    Europe PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Infectious Diseases, 2018–2030

Table 19    Europe PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 20    Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 21    Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Technology, 2018–2030

Table 22    Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Product, 2018–2030

Table 23    Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Application, 2018–2030

Table 24    Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Infectious Diseases, 2018–2030

Table 25    Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 26    Latin America PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 27    Latin America PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Technology, 2018–2030

Table 28    Latin America PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Product, 2018–2030

Table 29    Latin America PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Application, 2018–2030

Table 30    Latin America PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Infectious Diseases, 2018–2030

Table 31    Latin America PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 32    Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 33    Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Technology, 2018–2030

Table 34    Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Product, 2018–2030

Table 35    Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Application, 2018–2030

Table 36    Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Infectious Diseases, 2018–2030

Table 37    Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by End-user, 2018–2030

List of Figures

Figure 01    Global PCR & Real-time PCR Molecular Diagnostics  Market Value (US$ Mn) Forecast, 2018–2030

Figure 02    Global PCR & Real-time PCR Molecular Diagnostics  Market Value Share, by Technology, 2019

Figure 03    Global PCR & Real-time PCR Molecular Diagnostics  Market Value Share, by Product, 2019

Figure 04    Global PCR & Real-time PCR Molecular Diagnostics  Market Value Share, by Application, 2019

Figure 05    Global PCR & Real-time PCR Molecular Diagnostics  Market Value Share, by End-user, 2019

Figure 06    Global PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by Technology, 2019 and 2030

Figure 07    Global PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by Technology, 2019–2030

Figure 08    Global PCR & Real-time PCR Molecular Diagnostics  Market Value (US$ Mn), by Traditional PCR, 2018–2030

Figure 09    Global PCR & Real-time PCR Molecular Diagnostics  Market Value (US$ Mn), by Real-time PCR, 2018–2030

Figure 10    Global PCR & Real-time PCR Molecular Diagnostics  Market Value (US$ Mn), by Digital PCR, 2018–2030

Figure 11    Global PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by Product, 2019 and 2030

Figure 12    Global PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by Product, 2020–2030

Figure 13    Global PCR & Real-time PCR Molecular Diagnostics  Market Value (US$ Mn), by Instruments, 2018–2030

Figure 14    Global PCR & Real-time PCR Molecular Diagnostics  Market Value (US$ Mn), by Reagents, 2018–2030

Figure 15    Global PCR & Real-time PCR Molecular Diagnostics  Market Value (US$ Mn), by Consumables, 2018–2030

Figure 16    Global PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by Application, 2019 and 2030

Figure 17    Global PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by Application, 2020–2030

Figure 18    Global PCR & Real-time PCR Molecular Diagnostics  Market Value (US$ Mn), by Infectious Diseases, 2018–2030

Figure 19    Global PCR & Real-time PCR Molecular Diagnostics  Market Value (US$ Mn), by Oncology, 2018–2030

Figure 20    Global PCR & Real-time PCR Molecular Diagnostics  Market Value (US$ Mn), by Genetic Testing, 2018–2030

Figure 21    Global PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by Others, 2019 and 2030

Figure 22    Global PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by End-user, 2019 and 2030

Figure 23    Global PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by End-user 2020–2030

Figure 24    Global PCR & Real-time PCR Molecular Diagnostics  Market Value (US$ Mn), by Hospitals 2018–2030

Figure 25    Global PCR & Real-time PCR Molecular Diagnostics  Market Value (US$ Mn), by Diagnostic Laboratories, 2018–2030

Figure 26    Global PCR & Real-time PCR Molecular Diagnostics  Market Value (US$ Mn), by Academic & Research Institutes, 2018–2030

Figure 27    Global PCR & Real-time PCR Molecular Diagnostics  Market Value (US$ Mn), by Others, 2018–2030

Figure 28    Global PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by Region, 2019 and 2030

Figure 29    Global PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by Region, 2020–2030

Figure 30    North America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 31    North America PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by Country, 2019 and 2030

Figure 32    North America PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by Country, 2019–2030

Figure 33    North America PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by Technology, 2019 and 2030

Figure 34    North America PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by Technology, 2019–2030

Figure 35    North America PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by Product, 2019 and 2030

Figure 36    North America PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by Product, 2020–2030

Figure 37    North America PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by Application, 2019 and 2030

Figure 38    North America PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by Application, 2020–2030

Figure 39    North America PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by End-user, 2019 and 2030

Figure 40    North America PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by End-user, 2020–2030

Figure 41    Europe PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 42    Europe PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 43    Europe PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by Country/Sub-region, 2019–2030

Figure 44    Europe PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by Technology, 2019 and 2030

Figure 45    Europe PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by Technology, 2019–2030

Figure 46    Europe PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by Product, 2019 and 2030

Figure 47    Europe PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by Product, 2020–2030

Figure 48    Europe PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by Application, 2019 and 2030

Figure 49    Europe PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by Application, 2020–2030

Figure 50    Europe PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by End-user, 2019 and 2030

Figure 51    Europe PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by End-user, 2020–2030

Figure 52    Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 53    Asia Pacific PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 54    Asia Pacific PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by Country/Sub-region, 2019–2030

Figure 55    Asia Pacific PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by Technology, 2019 and 2030

Figure 56    Asia Pacific PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by Technology, 2019–2030

Figure 57    Asia Pacific PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by Product, 2019 and 2030

Figure 58    Asia Pacific PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by Product, 2020–2030

Figure 59    Asia Pacific PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by Application, 2019 and 2030

Figure 60    Asia Pacific PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by Application, 2020–2030

Figure 61    Asia Pacific PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by End-user, 2019 and 2030

Figure 62    Asia Pacific PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by End-user, 2020–2030

Figure 63    Latin America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 64    Latin America PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 65    Latin America PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by Country/Sub-region, 2019–2030

Figure 66    Latin America PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by Technology, 2019 and 2030

Figure 67    Latin America PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by Technology, 2019–2030

Figure 68    Latin America PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by Product, 2019 and 2030

Figure 69    Latin America PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by Product, 2020–2030

Figure 70    Latin America PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by Application, 2019 and 2030

Figure 71    Latin America PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by Application, 2020–2030

Figure 72    Latin America PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by End-user, 2019 and 2030

Figure 73    Latin America PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by End-user, 2020–2030

Figure 74    Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 75    Middle East & Africa PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 76    Middle East & Africa PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by Country/Sub-region, 2019–2030

Figure 77    Middle East & Africa PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by Technology, 2019 and 2030

Figure 78    Middle East & Africa PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by Technology, 2019–2030

Figure 79    Middle East & Africa PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by Product, 2019 and 2030

Figure 80    Middle East & Africa PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by Product, 2020–2030

Figure 81    Middle East & Africa PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by Application, 2019 and 2030

Figure 82    Middle East & Africa PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by Application, 2020–2030

Figure 83    Middle East & Africa PCR & Real-time PCR Molecular Diagnostics  Market Value Share Analysis, by End-user, 2019 and 2030

Figure 84    Middle East & Africa PCR & Real-time PCR Molecular Diagnostics  Market Attractiveness Analysis, by End-user, 2020–2030

Figure 85    Global PCR & Real-time PCR Molecular Diagnostics Market Share Analysis, by Company, 2019

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

974

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved